Evotec is a life science company with a core business in drug discovery and preclinical development, deploying cutting-edge technology across small molecules, biotherapeutics, and biologics. The threat model here isn't external adversaries - it's the complexity of biology itself, and the massive datasets, automated workflows, and proprietary platforms that hold sensitive research IP and preclinical data. With over 5,000 professionals operating across 17 locations in six countries, the attack surface is sprawling, and the stakes are measured in compromised pipelines and regulatory exposure, not just stolen credentials.
The company's division, Just – Evotec Biologics, focuses on revolutionizing the design, development, and manufacturing of biologics, which means a significant portion of their infrastructure supports computational biology, high-throughput screening, and manufacturing control systems. Cybersecurity roles here likely intersect with securing scientific computing environments, protecting intellectual property in a competitive pharmaceutical landscape, and ensuring the integrity of data that feeds into drug development decisions. The technical domains - drug discovery, preclinical development, biologics design - demand teams that understand both the science and the security posture required to defend it.
Evotec operates globally with a culture emphasizing scientific excellence and innovation, structured around flexible partnering models with other pharmaceutical and biotech entities. This means security teams aren't just defending an internal perimeter; they're managing trust boundaries across collaborative research networks, joint development programs, and outsourced manufacturing workflows. The operational scope requires professionals who can reason about supply chain risk, data provenance, and the specific compliance regimes governing life sciences - GLP, GMP, and the regulatory frameworks that treat a data integrity failure as a patient safety issue.
